Renal Impairment Study

NCT00863161 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux
Renal Excretion

Interventions

DRUG: AZD3355

Sponsor

AstraZeneca